BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 31097977)

  • 1. Potential Applications of NRF2 Inhibitors in Cancer Therapy.
    Panieri E; Saso L
    Oxid Med Cell Longev; 2019; 2019():8592348. PubMed ID: 31097977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of Nrf2 in tumor progression and its inhibitors in cancer therapy].
    Tian ZY; Yang Y
    Zhongguo Zhong Yao Za Zhi; 2021 Jan; 46(1):24-32. PubMed ID: 33645047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and development of Nrf2 modulators for cancer chemoprevention and therapy: a review.
    Sova M; Saso L
    Drug Des Devel Ther; 2018; 12():3181-3197. PubMed ID: 30288023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.
    Taguchi K; Motohashi H; Yamamoto M
    Genes Cells; 2011 Feb; 16(2):123-40. PubMed ID: 21251164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Keap1-Nrf2 cell defense pathway--a promising therapeutic target?
    Copple IM
    Adv Pharmacol; 2012; 63():43-79. PubMed ID: 22776639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Dual Roles of NRF2 in Cancer.
    Menegon S; Columbano A; Giordano S
    Trends Mol Med; 2016 Jul; 22(7):578-593. PubMed ID: 27263465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecular Nrf2 inhibitors as chemosensitizers for cancer therapy.
    Lin H; Qiao Y; Yang H; Nan Q; Qu W; Feng F; Liu W; Chen Y; Sun H
    Future Med Chem; 2020 Feb; 12(3):243-267. PubMed ID: 31950858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of NRF2 signaling pathway by nuclear receptors: implications for cancer.
    Namani A; Li Y; Wang XJ; Tang X
    Biochim Biophys Acta; 2014 Sep; 1843(9):1875-85. PubMed ID: 24851839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Applications of Nrf2 Inhibitors as Potential Antineoplastic Drugs.
    Telkoparan-Akillilar P; Suzen S; Saso L
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31022969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy.
    Zhu J; Wang H; Chen F; Fu J; Xu Y; Hou Y; Kou HH; Zhai C; Nelson MB; Zhang Q; Andersen ME; Pi J
    Free Radic Biol Med; 2016 Oct; 99():544-556. PubMed ID: 27634172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting NRF2 and Its Downstream Processes: Opportunities and Challenges.
    Torrente L; DeNicola GM
    Annu Rev Pharmacol Toxicol; 2022 Jan; 62():279-300. PubMed ID: 34499527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances of Natural Polyphenols Activators for Keap1-Nrf2 Signaling Pathway.
    Zhou Y; Jiang Z; Lu H; Xu Z; Tong R; Shi J; Jia G
    Chem Biodivers; 2019 Nov; 16(11):e1900400. PubMed ID: 31482617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the Keap1-Nrf2 pathway in cancer.
    Leinonen HM; Kansanen E; Pölönen P; Heinäniemi M; Levonen AL
    Adv Cancer Res; 2014; 122():281-320. PubMed ID: 24974185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer.
    Choi EJ; Jung BJ; Lee SH; Yoo HS; Shin EA; Ko HJ; Chang S; Kim SY; Jeon SM
    Oncogene; 2017 Sep; 36(37):5285-5295. PubMed ID: 28504720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic versus Genetic Deregulation of the KEAP1/NRF2 Axis in Solid Tumors: Focus on Methylation and Noncoding RNAs.
    Fabrizio FP; Sparaneo A; Trombetta D; Muscarella LA
    Oxid Med Cell Longev; 2018; 2018():2492063. PubMed ID: 29643973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Keap1-Nrf2 system as an in vivo sensor for electrophiles.
    Uruno A; Motohashi H
    Nitric Oxide; 2011 Aug; 25(2):153-60. PubMed ID: 21385624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development.
    Robledinos-Antón N; Fernández-Ginés R; Manda G; Cuadrado A
    Oxid Med Cell Longev; 2019; 2019():9372182. PubMed ID: 31396308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nrf2 in cancers: A double-edged sword.
    Wu S; Lu H; Bai Y
    Cancer Med; 2019 May; 8(5):2252-2267. PubMed ID: 30929309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters.
    Bai X; Chen Y; Hou X; Huang M; Jin J
    Drug Metab Rev; 2016 Nov; 48(4):541-567. PubMed ID: 27320238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward clinical application of the Keap1-Nrf2 pathway.
    Suzuki T; Motohashi H; Yamamoto M
    Trends Pharmacol Sci; 2013 Jun; 34(6):340-6. PubMed ID: 23664668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.